| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| STRECK PAUL | EVP, Head of R&D | C/O PEPGEN INC., 321 HARRISON AVE., 8TH FL, BOSTON | /s/ Noel Donnelly, as attorney-in-fact | 02 Mar 2026 | 0001708063 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PEPG | Common Stock | Award | $0 | +50,300 | +181% | $0.000000 | 78,105 | 01 Mar 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PEPG | Stock Option (Right to Buy) | Award | $0 | +196,500 | $0.000000 | 196,500 | 01 Mar 2026 | Common Stock | 196,500 | $6.22 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Consists of 50,300 restricted stock units ("RSUs"), each representing the contingent right to receive one share of Common Stock upon vesting. The RSUs vest in equal annual installments over four years, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
| F2 | This option shall vest and become exercisable as follows: 25% of the shares on the one-year anniversary of the Grant Date, with the remaining 75% vesting and becoming exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |